ONE OF THE potential variables affecting the overall survival and qual
ity of life of patients with intracranial gliomas is the extent of tum
or resection that results in the smallest volume of residual disease.
A technique involving enhanced optical imaging of human gliomas has th
e potential to localize tumors, identify tumor remaining at the resect
ion margins, and determine the grade of the tumor. In a preliminary st
udy involving nine patients undergoing surgery for the removal of intr
insic brain tumors, enhanced optical imaging was performed using indoc
yanine green as an intravenous contrast-enhancement agent. Optical ima
ges were obtained before and after injection of the indocyanine green.
The studies in the nine patients showed differences in the dynamic op
tical signals among normal brain, low-grade astrocytomas, and malignan
t astrocytomas. Optical imaging of the resection margins in malignant
tumors showed differences between adjacent normal tissue and remaining
tumor tissue. Enhanced optical imaging of human gliomas using a contr
ast-enhancing dye, indocyanine green, provides a potential means to di
fferentiate between normal brain and tumor tissue at the cortical surf
ace and in the depths of the resection margins. Having the ability to
obtain real-time information and feedback in the operating room may al
low neurosurgeons to maximize the extent of tumor resection while spar
ing normal brain and increasing the diagnostic accuracy of intraoperat
ive biopsies. Enhanced optical imaging potentially could facilitate th
e accuracy and safety of surgery when tumors are removed at sites even
outside the central nervous system.